The eco-morphological changes of internal organs at subjects with post-COVID-19 thyroid gland diseases

The eco-morphological changes of internal organs at subjects with post-COVID-19 thyroid gland diseases


  • Anghela CEBOTARI Institutul de Fiziologie și Sanocreatologie, Universitatea de Stat de Medicină Și Farmacie „N. Testemițanu”



thyroid gland, ecomorphology, postcovid period, disease, internal organs


Covid-19 is a serious and aggressive disease that affects all systems of the human body manifesting itself through various complications, most of which last (thyroid gland, lungs, liver, kidneys, gallbladder, nervous system, genital system, bone system, etc.). Patients require a complex investigation with a thorough analysis of all investigations performed to apply a more effective treatment, reducing postcovid complications.

Author Biography

Anghela CEBOTARI, Institutul de Fiziologie și Sanocreatologie, Universitatea de Stat de Medicină Și Farmacie „N. Testemițanu”

doctorandă, cercetător științific.


НАСОНОВ, Е.Л. Коронавирусная болезнь 2019 (COVID-19): размышления ревматолога. Научно-практическая ревматология. 2020, 58(2), 123-132. doi. org/10.14412/1995-4484-2020-123-132

AL GHAMDI, M., ALGHAMDI, K.M., GHANDOORA, Y. et al. Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. BMC infectious diseases. 2016, 16(1), 174.

AMANN, K., BOOR, P., WIECH, T. et al. COVID-19 effects on the kidney. Pathologe. 2021, 1, 1-5. doi: 10.1007/s00292-020-00900-x.

ASKARI, H., SANADGOL, N., AZARNEZHAD,A. et al. Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon. 2021, 7(1), e06008. doi: 10.1016/j.heliyon.2021. e06008

BUDI EH, SCHAUB JR, DECARIS M, TURNER S, DERYNCK R. TGF-beta as a driver of fibrosis: Physiological roles and therapeutic opportunities. J Pathol. 2021, 254(4), 358-373. doi: 10.1002/path.5680.

CAPACCIONE, K.M., YANG, H., WEST, E. et al. Pathophysiology and imaging findings of COVID-19 infection: An organ-system based review. Acad Radiol. 2021, 28(5), 595-607. doi: 10.1016/j.acra.2021.01.022

DARIF, D., HAMMI, I., KIHEL, A., EL IDRISSI SAIK, I., GUESSOUS, F., AKARID, K. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microb Pathog. 2021, 18(153), 104799. doi: 10.1016/j.micpath.2021.104799

DE GIORGIO, M.R., DI NOIA, S., MORCIANO, C., CONTE, D. The impact of SARS-CoV-2 on skeletal muscles. Acta Myol. 2020, 1, 39(4), 307-312. doi: 10.36185/2532-1900-034.

FAN, B.E., CHONG, V.C.L., CHAN, S.S.W. et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020, 95(6), E131-E134. doi: 10.1002/ajh.25774.

FERRARA, F., VITIELLO, A. Scientific and pharmacological rationale for the treatment of cardiac damage caused by COVID-19. Discov Med. 2020, 30(161), 155-161.

HIGGINS, V., SOHAEI, D., DIAMANDIS, E.P., PRASSAS, I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2020, 21, 1-23. doi: 10.1080/10408363.2020.1860895.

MARTINS-FILHO, P.R., TAVARES, C.S.S., SANTOS, V.S. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. European journal of internal medicine, 76 (2020), 97-99.

MATUIZZI, C., LIPPI, G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med. 2020, 8, 48.

MCDONALD, L.T. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021, 320(2), L257-L265. doi: 10.1152/ajplung.00238.2020.

OSTERGAARD, L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021, 9(3), e14726. doi: 10.14814/phy2.14726.

PLAÇAIS, L, RICHER, Q. COVID-19: caractéristiquescliniques, biologiques et radiologiques chez l’adulte, la femme enceinte et l’enfant. Une mise au point au cœur de la pandémie. Rev Med Interne. 2020, 41, 308-318.

ROSSI, P.G., MARINO, M., FORMISANO, D. et al. Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy. PLoS One. 2020, 15(8), e0238281. doi: 10.1371/journal. pone.0238281. eCollection 2020.

SCAPPATICCIO, L., PITOIA, F., ESPOSITO, K. et al. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020, 1-13. doi: 10.1007/s11154-020-09615-z.

SHCHENDRYGINA, A., NAGEL, E., PUNTMANN, V.O., VALBUENA-LOPEZ, S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 2021, 19(1), 5-14. doi: 10.1080/14779072.2021.1844005.

SPEER, G., SOMOGYI, P. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19). Endocr J. 2021, 68(2), 129-136. doi: 10.1507/endocrj.EJ20-0443.

WANG, K., QIU, Z., LIU, J. et AL. Analysis of the clinical characteristics of 77 COVID-19 deaths. Scientific Reports, 2020, 10, p. 16384.

WU, F., ZHAO, S., YU, B. et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020, 579, 265–269.

ZHANG, C., WU, Z., LI, J.W. et al. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19. J Med Virol. 2021, 93(3), 1378-1386. doi: 10.1002/jmv.26634.





Research Article